Improving Treatment Response Prediction for Chemoradiation Therapy of Pancreatic Cancer Using a Combination of Delta-Radiomics and the Clinical Biomarker CA19-9

Abstract

Recently we showed that delta radiomics features (DRF) from daily CT-guided chemoradiation therapy (CRT) is associated with early prediction of treatment response for pancreatic cancer. CA19-9 is a widely used clinical biomarker for pancreatic cancer. The purpose of this work is to investigate if the predictive power of such biomarkers (DRF or CA19-9) can improve by combining both biomarkers. Daily non-contrast CTs acquired during routine CT-guided neoadjuvant CRT for 24 patients (672 datasets, in 28 daily fractions), along with their CA19-9, pathology reports and follow-up data were analyzed. The pancreatic head was segmented on each daily CT and radiomic features were extracted from the segmented regions. The time between the end of treatment and last follow-up was used to build a survival model. Patients were divided into two groups based on their pathological response. Spearman correlations were used to find the DRFs correlated to CA19-9. A regression model was built to examine the effect of combining CA19-9 and DRFs on response prediction. C-index was used to measure model effectiveness. The effect of a decrease in CA19-9 levels during treatment vs. failure of CA19-9 levels to normalize on survival was examined. Univariate-and multivariate Cox-regression analysis were performed to determine the effect of combining CA19-9 and DRFs on survival correlations. Spearman correlation showed that CA19-9 is correlated to DRFs (Entropy, cluster tendency and coarseness). An Increase in CA19-9 levels during treatment were correlated to a bad response, while a decline was correlated to a good response. Incorporating CA19-9 with DRFs increased the c-index from 0.57 to 0.87 indicating a stronger model. The univariate analysis showed that patients with decreasing CA19-9 had an improved median survival (68 months) compared to those with increasing levels (33 months). The 5-years survival was improved for the decreasing CA19-9 group (55%) compared to the increasing group (30%). The Cox-multivariate analysis showed

Radiomics-Based Outcome Prediction for Pancreatic Cancer Following Stereotactic Body Radiotherapy

“…Another application of radiomics not explored by our study is the use of delta-radiomics to assess treatment response [13]. By comparing the differences in patients' longitudinal radiomic data as they progress through treatment, researchers were able to assess treatment response earlier and more reliably than current methods of assessment, such as trending CA-19-9, in pancreatic cancer [14]. A recent study performed by Nardone et al further suggests that the use of radiomics in tracking treatment response is better accomplished by the analysis of delta-radiomics than of a single radiomic dataset [15].…”

Imaging Biomarkers to Predict and Evaluate the Effectiveness of Immunotherapy in Advanced Non-Small-Cell Lung Cancer

“…Nevertheless, further evaluation needs to be carried out in translating such research into clinical practice because most literature in the field had a multi-localization/multi-type tumor cohort design. Deltaradiomics features (Delta-RFs) which capture therapy-induced changes in radiomics features are now being evaluated as a complement to Response Evaluation Criteria in Solid Tumor (RECIST) criteria for monitoring therapeutic response in several tumor types (25)(26)(27)(28)(29)(30)(31). Khorrami et al showed preliminary evidence for clinical use of Delta-radiomics calculated from contrast-enhanced CT images as predictive biomarkers of response to ICIs therapy in NSCLC (31).…”

Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Guided Radiotherapy

“…Then, the same authors combined the previously described Delta Radiomic model with a widely used clinical biomarker for pancreatic cancer (CA19-9), demonstrating how the integration of the two predictors leads to more reliable predictive performance than considering the individual parameters alone [ 43 ].…”